Total Utang marang Modal OS Therapies Inc (OSTX)

OS Therapies - logo grafis emiten OSTX

OS Therapies Incorporated (OSTX) is a biotech startup developing drugs for rare pediatric bone tumors tailored for specialized clinics. Management is focusing on immunotherapy within niches lacking effective solutions. This price chart reflects the separate_debt_total_eq metric at 0.00. The company is currently conducting tests against osteosarcoma while seeking grants and partnerships with pharma behemoths to fund its research.

ostherapies.com (OSTX): Rasio Utang marang Ekuitas saka 02.08.2024 nganti 31.10.2026

Rincian metrik lan analitis perusahaan OS Therapies, Inc. (OSTX)

- rega saham lan konsensus proyeksi valuasi:
Rega saham OS Therapies|OSTX - Target konsensus
- rincian kapitalisasi pasar:
Kapitalisasi pasar OS Therapies|OSTX - Nilai Perusahaan
- indikator kapitalisasi buku:
Aset Bersih saben Siji Saham OS Therapies|OSTX - Kapitalisasi Akuntansi|Rasio Kapitalisasi Pasar marang Nilai Buku ostherapies.com|OSTX - Gunggung Aset Perusahaan
- rincian utang lan likuiditas:
Total Utang marang Modal OS Therapies Incorporated|OSTX - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas OS Therapies Incorporated|OSTX - Kewajiban utang agregat|Utang marang nilai buku OS Therapies|OSTX - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan OS Therapies|Indikator likuiditas cepet ostherapies.com
- data bathi resik lan rasio valuasi:
OSTX - Bathi resik
Pambiji fundamental perusahaan:OS Therapies
Produk dadi OS Therapies Incorporated

Low leverage enhances the investment profile of OS Therapies Incorporated (OSTX), minimizing financial risks while scaling capital-intensive developments. By analyzing the debt-to-equity chart, investors can assess the balance between borrowed funds and owner assets, which is critical for OS Therapies Incorporated (OSTX) when implementing costly robotic bioscreening systems and AI models in oncological research.

Analisis pesaing OS Therapies Incorporated

ONC (BeiGene) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas Halozyme Therapeutics, Inc. (HALO)|Total Utang marang Modal RVMD|Total Utang marang Modal Ascentage Pharma Corp (AAPG)|Utang marang Ekuitas CG Oncology, Inc. CGON|URGN: Rasio Utang marang Ekuitas|Bicara Therapeutics - Total Utang marang Modal|Personalis Inc (PSNL) - Rasio Total Utang marang Ekuitas|ERAS: Total Utang marang Modal|Utang marang Modal Delcath Corp (DCTH)|Utang marang Ekuitas Y-mAbs Therapeutics|AURA: Rasio Kabeh Utang marang Dana Pribadi|Rasio Total Utang marang Ekuitas CADL (Candel Therapeutics)|ARAY (Accuray Inc) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal SLS (SELLAS Life Sciences Group)|ACTU - Rasio Total Utang marang Ekuitas|CTOR: Rasio Total Utang marang Ekuitas|HURA - Total Utang marang Modal|Protara Therapeutics, Inc. (TARA) - Utang marang Ekuitas|Fate Therapeutics Inc - Rasio Kabeh Utang marang Dana Pribadi|WHWK (Aadi Bioscience, Inc.) - Total Utang marang Modal|Utang marang Modal TScan TCRX|Utang marang Ekuitas Champions Oncology (CSBR)|XBIT - Utang marang Modal|Utang marang Ekuitas CEL-SCI CVM|Koefisien Total Utang marang Modal radiopharmtheranostics.com (RADX)|ARTV: Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi ANL (Adlai Nortye Ltd.)|VERU (Veru Inc.) - Rasio Total Utang marang Ekuitas|TPST: Utang Agregat marang Modal|XLO (Xilio Therapeutics Inc) - Total Utang marang Modal|RENB: Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal MURA|KAPA - Utang marang Modal|Utang marang Ekuitas OnKure Therapeutics OKUR|Rasio Kabeh Utang marang Dana Pribadi GDTC|Curis Corp - Total Utang marang Modal|APLM - Total Utang marang Modal|Tharimmune Corp (THAR) - Utang marang Ekuitas|Utang Agregat marang Ekuitas ADVB (Advanced Biomed)|GNPX (Genprex, Inc.) - Total Utang marang Modal|Calidi Bio (CLDI) - Koefisien Total Utang marang Modal|Total Utang marang Modal SBFM|XBIO - Utang marang Modal|Utang marang Ekuitas Salarius SLRX|Koefisien Total Utang marang Modal Kitov Pharma (PPBT)|AONC: Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi BGNE (beigene.com)|CKPT: Total Utang marang Modal|ELEV - Koefisien Total Utang marang Modal|Utang marang Ekuitas iCAD Inc.|Rasio Utang marang Ekuitas IKNA (Ikena)|Total Utang marang Modal NTBL|Rasio Total Utang marang Ekuitas viracta.com VIRX|Utang marang Ekuitas MorphoSys MOR|NAYA Biosciences Inc (NAYA) - Utang marang Modal|AAPGV - Utang marang Ekuitas